SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study

Background: The potential benefits of intervention with empagliflozin or dapagliflozin for patients with heart failure with preserved ejection fraction (HFpEF) were first demonstrated in the EMPEROR-Preserved and DELIVER studies. However, the cost-effectiveness of this intervention (empagliflozin or...

Full description

Saved in:
Bibliographic Details
Main Authors: He Lu (Author), Pingping Shang (Author), Dexing Zhou (Author)
Format: Book
Published: Frontiers Media S.A., 2023-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available